欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/1399/005
药品名称
Brieka
活性成分
Pregabalin 150.0 mg
剂型
Capsule, hard
上市许可持有人
Teva B.V. Netherlands
参考成员国 - 产品名称
Sweden (SE)
互认成员国 - 产品名称
Iceland (IS)
Brieka 150 mg hart hylki
Greece (GR)
ERLICENT
Latvia (LV)
Brieka 150 mg cietās kapsulas
Lithuania (LT)
Brieka 150 mg kietosios kapsulės
Estonia (EE)
BRIEKA
Bulgaria (BG)
Brieka
Slovakia (SK)
Brieka 150 mg
许可日期
2015/06/11
最近更新日期
2025/01/29
药物ATC编码
N03AX16 pregabalin
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final SPC
|
SE_H_1399_001_008_WS_1890_Pregabalin_FINAL_SmPC_cv
Date of last change:2025/01/28
Final PL
|
SE_H_1399_005_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_1399_005_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_1399_005_PAR
Date of last change:2024/09/06
PubAR Summary
|
SE_H_1399_005_PAR Summary
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase